Why isn’t there concern that by prematurely requiring highly credentialed people, by law, to do cryonics stabilizations that the government itself wouldn’t be misleading people about the legitimacy of cryonics?
I agree this is a major concern. What’s the standard procedure in medicine for experimental treatments? As far as I’m aware (and I am not a doctor), subjects generally don’t pay for them (I do know a lot of drug trials occur in Texas because you can compensate the subjects, so apparently the cash flow is in the opposite direction for at least one other field).
And so the most appropriate model for cryonics right now might be “if you want to volunteer your body at death, we’d like to try to get better at preserving people.” That strikes me as a lot more honest than charging people for a service, and make it a lot clearer what’s going on. In efficient markets, prices convey information- and so a pretty common bias is to consider price a good proxy of quality.
And so the most appropriate model for cryonics right now might be “if you want to volunteer your body at death, we’d like to try to get better at preserving people.” That strikes me as a lot more honest than charging people for a service, and make it a lot clearer what’s going on. In efficient markets, prices convey information- and so a pretty common bias is to consider price a good proxy of quality.
Does anyone have a realistic commercial interest in developing cryonics based treatments?
I agree this is a major concern. What’s the standard procedure in medicine for experimental treatments? As far as I’m aware (and I am not a doctor), subjects generally don’t pay for them (I do know a lot of drug trials occur in Texas because you can compensate the subjects, so apparently the cash flow is in the opposite direction for at least one other field).
And so the most appropriate model for cryonics right now might be “if you want to volunteer your body at death, we’d like to try to get better at preserving people.” That strikes me as a lot more honest than charging people for a service, and make it a lot clearer what’s going on. In efficient markets, prices convey information- and so a pretty common bias is to consider price a good proxy of quality.
Does anyone have a realistic commercial interest in developing cryonics based treatments?